Chronic Coronary Disease Guideline E3: Treatment Recommendation Highlights
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of member benefits, join or renew today.
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Statins are an essential therapy in the management of CCD, and this guideline has some important updates for how they can best be utilized, including in conjunction with other therapies. Dr. Virani and Dr. Newby discuss those recommendations and other detailed aspects of treatment, including antiplatelet therapy, beta blockers, and revascularization. They also go into weight loss and discuss the role that SGLT2 inhibitors or a GLP-1 receptor agonists can play in treatment. They also touch on how to approach special populations, including those with HIV/AIDS, cancer, pregnant women, and young people.
Recommended Videos
Key Diagnostic Points from the Kawasaki Disease Statement
Future Directions of Kawasaki Disease
Advancements in the Treatment of Kawasaki Disease
Acute and Long Term Imaging Management for Kawasaki Disease
Updates on Echocardiograms for Measurements of the Coronary Artery in Pati...
Loading...
Save Video
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.